Successful oral desensitization and reintroduction in selected glioma patients with procarbazine-mediated hypersensitivity

Allergy. 2020 Nov;75(11):2974-2976. doi: 10.1111/all.14428. Epub 2020 Jun 24.

Authors

Hester Van der Valk¹, Hilda Dijkstra², Annemiek Walenkamp³, Marie L A Schuttelaar⁴, Hanneke N G Oude Elberink¹, Annick A J M Van de Ven¹

Affiliations

¹ Department of Internal Medicine and Allergology, University Medical Center Groningen, Groningen, The Netherlands.
² Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, Groningen, The Netherlands.
³ Department of Medical Oncology, University Medical Center Groningen, Groningen, the Netherlands.
⁴ Department of Dermatology, University Medical Center Groningen, Groningen, the Netherlands.

PMID: 32484932
DOI: 10.1111/all.14428

No abstract available

Publication types

Letter

MeSH terms

Desensitization, Immunologic
Drug Hypersensitivity* / diagnosis
Drug Hypersensitivity* / etiology
Drug Hypersensitivity* / therapy
Glioma* / drug therapy
Humans
Procarbazine

Substances

Procarbazine